Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.

Saved in:
Bibliographic Details
Title: Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
Authors: Lee H; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea., Jeong S; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Medicinal Materials Research Center, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea., Park J; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea., Son HJ; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea., Kweon S; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea., Lee SS; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, IL, USA., Shim N; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea., Oh Y; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea., Kang H; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea., Lee C; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea., Lee J; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea., Kim J; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea., Cho H; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Noxpharm Co., LTD., Seoul 03759, Republic of Korea., Kim K; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.
Source: Theranostics [Theranostics] 2026 Apr 23; Vol. 16 (11), pp. 6240-6265. Date of Electronic Publication: 2026 Apr 23 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42094600
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.<br /><searchLink fieldCode="AU" term="%22Jeong+S%22">Jeong S</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Medicinal Materials Research Center, Biomedical Research Division, Medicinal Materials Research Center, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+HJ%22">Son HJ</searchLink>; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kweon+S%22">Kweon S</searchLink>; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SS%22">Lee SS</searchLink>; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Shim+N%22">Shim N</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oh+Y%22">Oh Y</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+H%22">Kang H</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+H%22">Cho H</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Noxpharm Co., LTD., Seoul 03759, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+K%22">Kim K</searchLink>; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.; Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2026 Apr 23; Vol. 16 (11), pp. 6240-6265. <i>Date of Electronic Publication: </i>2026 Apr 23 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42094600
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7150/thno.130510
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6240
    Titles:
      – TitleFull: Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee H
      – PersonEntity:
          Name:
            NameFull: Jeong S
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Son HJ
      – PersonEntity:
          Name:
            NameFull: Kweon S
      – PersonEntity:
          Name:
            NameFull: Lee SS
      – PersonEntity:
          Name:
            NameFull: Shim N
      – PersonEntity:
          Name:
            NameFull: Oh Y
      – PersonEntity:
          Name:
            NameFull: Kang H
      – PersonEntity:
          Name:
            NameFull: Lee C
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Cho H
      – PersonEntity:
          Name:
            NameFull: Kim K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 04
              Text: 2026 Apr 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1838-7640
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Theranostics
              Type: main
ResultId 1